BRIEF-Ac Immune Says Informed Enrollment Has Been Temporarily Paused For Phase 2B Retain Trial

Reuters
11 hours ago
BRIEF-Ac Immune Says Informed Enrollment Has Been Temporarily Paused For Phase 2B Retain Trial

Feb 17 (Reuters) - AC Immune SA ACIU.O:

  • AC IMMUNE SA: INFORMED BY JANSSEN PHARMACEUTICALS THAT ENROLLMENT HAS BEEN TEMPORARILY PAUSED FOR PHASE 2B RETAIN TRIAL

  • AC IMMUNE SA: TEMPORARY PAUSE IN PHASE 2B RETAIN TRIAL RECRUITMENT IS VOLUNTARY & NOT RELATED TO NEW SAFETY FINDINGS

Source text: [ID:n0000950103-26-002195]

Further company coverage: ACIU.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10